413 related articles for article (PubMed ID: 37482145)
1. The antipsychotic olanzapine reduces memory deficits and neuronal abnormalities in a male rat model of Autism.
Lima-Castañeda LÁ; Bringas ME; Aguilar-Hernandez L; Garcés-Ramírez L; Morales-Medina JC; Flores G
J Chem Neuroanat; 2023 Oct; 132():102317. PubMed ID: 37482145
[TBL] [Abstract][Full Text] [Related]
2. Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid.
Davoudi S; Rahdar M; Hosseinmardi N; Behzadi G; Janahmadi M
Physiol Behav; 2023 Oct; 269():114286. PubMed ID: 37402416
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the intrinsic discharge activity of CA1 pyramidal neurons associated with possible changes in the NADPH diaphorase activity in a rat model of autism induced by prenatal exposure to valproic acid.
Rahdar M; Hajisoltani R; Davoudi S; Karimi SA; Borjkhani M; Khatibi VA; Hosseinmardi N; Behzadi G; Janahmadi M
Brain Res; 2022 Oct; 1792():148013. PubMed ID: 35841982
[TBL] [Abstract][Full Text] [Related]
4. Influence of environmental enrichment on sexual behavior and the process of learning and memory in a rat model of autism with valproic acid.
Javik Dorantes-Barrios C; Reyes-Meza V; Camacho-Candia JA; Pfaus JG; González-Flores O
Brain Res; 2024 Mar; 1827():148738. PubMed ID: 38142724
[TBL] [Abstract][Full Text] [Related]
5. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
[TBL] [Abstract][Full Text] [Related]
6. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
7. Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats.
Sandhu A; Rawat K; Gautam V; Bhatia A; Grover S; Saini L; Saha L
Pharmacol Biochem Behav; 2024 Apr; 237():173721. PubMed ID: 38307465
[TBL] [Abstract][Full Text] [Related]
8. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the Hippocampal Networks in Valproic Acid-Induced Rat Autism Model.
Bódi V; Májer T; Kelemen V; Világi I; Szűcs A; Varró P
Front Neural Circuits; 2022; 16():772792. PubMed ID: 35185478
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism.
Takuma K; Hara Y; Kataoka S; Kawanai T; Maeda Y; Watanabe R; Takano E; Hayata-Takano A; Hashimoto H; Ago Y; Matsuda T
Pharmacol Biochem Behav; 2014 Nov; 126():43-9. PubMed ID: 25240644
[TBL] [Abstract][Full Text] [Related]
11. 5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
Matsuo K; Yabuki Y; Fukunaga K
Neuropharmacology; 2020 May; 168():107975. PubMed ID: 31991146
[TBL] [Abstract][Full Text] [Related]
12. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist.
Taheri F; Esmaeilpour K; Sepehri G; Sheibani V; Shekari MA
Behav Pharmacol; 2023 Jun; 34(4):179-196. PubMed ID: 37171458
[TBL] [Abstract][Full Text] [Related]
14. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
[TBL] [Abstract][Full Text] [Related]
15. Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism.
Codagnone MG; Podestá MF; Uccelli NA; Reinés A
Dev Neurosci; 2015; 37(3):215-31. PubMed ID: 25895486
[TBL] [Abstract][Full Text] [Related]
16. Music alleviates cognitive impairments in an animal model of autism.
Taheri F; Joushi S; Esmaeilpour K; Sheibani V; Ebrahimi MN; Taheri Zadeh Z
Int J Dev Neurosci; 2023 Aug; 83(5):399-416. PubMed ID: 37246451
[TBL] [Abstract][Full Text] [Related]
17. Hyperexcitability of hippocampal CA1 pyramidal neurons in male offspring of a rat model of autism spectrum disorder (ASD) induced by prenatal exposure to valproic acid: A possible involvement of Ih channel current.
Hajisoltani R; Karimi SA; Rahdar M; Davoudi S; Borjkhani M; Hosseinmardi N; Behzadi G; Janahmadi M
Brain Res; 2019 Apr; 1708():188-199. PubMed ID: 30537517
[TBL] [Abstract][Full Text] [Related]
18. Histamine H3 receptor antagonist, ciproxifan, alleviates cognition and synaptic plasticity alterations in a valproic acid-induced animal model of autism.
Taheri F; Esmaeilpour K; Sepehri G; Sheibani V; Ur Rehman N; Maneshian M
Psychopharmacology (Berl); 2022 Aug; 239(8):2673-2693. PubMed ID: 35538250
[TBL] [Abstract][Full Text] [Related]
19. 5-HT7 receptor activation rescues impaired synaptic plasticity in an autistic-like rat model induced by prenatal VPA exposure.
Khodaverdi M; Rahdar M; Davoudi S; Hajisoltani R; Tavassoli Z; Ghasemi Z; Amini AE; Hosseinmardi N; Behzadi G; Janahmadi M
Neurobiol Learn Mem; 2021 Sep; 183():107462. PubMed ID: 34015444
[TBL] [Abstract][Full Text] [Related]
20. Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
Hara Y; Ago Y; Taruta A; Hasebe S; Kawase H; Tanabe W; Tsukada S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Psychopharmacology (Berl); 2017 Nov; 234(21):3217-3228. PubMed ID: 28798977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
